Page last updated: 2024-12-08

s-(1,2-dicarboxyethyl)glutathione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

S-(1,2-dicarboxyethyl)glutathione: isolated from calf lens; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9802383
SCHEMBL ID1590302
MeSH IDM0123265

Synonyms (17)

Synonym
s-(1,2-dicarboxyethyl)glutathione
1115-52-2
348q89naq9 ,
butanedioic acid, ((2-((4-amino-4-carboxy-1-oxobutyl)amino)-3-((carboxymethyl)amino)-3-oxopropyl)thio)-,
unii-348q89naq9
SCHEMBL1590302
PWCIUOASSAHGHI-WPZUCAASSA-N
s-(alpha,beta-dicarboxyethyl)glutathione
s-(alpha, beta-dicarboxyethyl)glutathione
s-(1,2-dicarboxyethyl)glutathione, >=95.0% (hplc)
mfcd00236956
2-((r)-2-((s)-4-amino-4-carboxybutanamido)-3-(carboxymethylamino)-3-oxopropylthio)succinic acid
2-[(2r)-2-[[(4s)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanylbutanedioic acid
succinic acid, ((2-(4-amino-4-carboxybutyramido)-2-((carboxymethyl)carbamoyl)ethyl)thio)-
((2-(4-amino-4-carboxybutyramido)-2-((carboxymethyl)carbamoyl)ethyl)thio)succinic acid
glycine, l-.gamma.-glutamyl-s-(1,2-dicarboxyethyl)-l-cysteinyl-
2-(2-((4-amino-5-hydroxy-5-oxopentanoyl)amino)-3-(carboxymethylamino)-3-oxopropyl)sulfanylbutanedioic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's9 (64.29)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]